Alexandra C Simpson, MD, MA1, Sandra D. Cassard, ScD2, Michael Comisac, n/a3, Danielle Obando, n/a3, Kathleen M Zackowski, PhD, OT4, Daniel Becker, MD5, Jennifer Keller, MSPT6 and Scott D. Newsome, DO, MSCS, FAAN, FANA1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins School of Medicine, Baltimore, MD, (3)Johns Hopkins University School of Medicine, Baltimore, MD, (4)National Multiple Sclerosis Society, New York, NY, (5)International Neurorehabilitation Institute, Lutherville-Timonium, MD, (6)Kennedy Krieger Institute, Baltimore, MD

Emily Gard, SPT1, Charlotte Rutherford, PT, DPT2, Jared Labrum, PTA1, Bet Hawley, PTA1, James Davis, SPT1 and Hina Garg, PT, MS, PhD, NCS1, (1)Rocky Mountain University of Health Professions, Provo, UT, (2)Boston, MA

Francois Bethoux, MD1,2, Samantha Stallkamp Tidd, BS3, Nicolas Thompson, M.S.4 and Susan M Linder, DPT2, (1)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Department of Physical Medicine and Rehabilitation, Cleveland Clinic, Cleveland, OH, (3)Cleveland Clinic Lerner College of Medicine, Cleveland, OH, (4)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH

Juliana AR Telles, physicaltherapist1, Alice E Dias, Dr2, Mauricio O Bando, Neuropsychologist3, Bruna Sciarini, physicaltherapist4, Demetrios Agourakis, doctor1, Giovanna Vidigal, physicaltherapist5, André Caetano, physical educator4 and Talita Dias, physicaltherapist6, (1)neurologia, Associação Brasileira de Esclerose Múltipla, São Paulo, Brazil, (2)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, (4)Associação Brasileira de Esclerose Múltipla, são paulo, Brazil, (5)neurologia, Universidade de São Paulo, são paulo, Brazil, (6)Universidade de São Paulo, São Paulo, Brazil

Thomas Edwards, PhD, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada, Afolasade Fakolade, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, Katherine Lindale, BSc, Department of Neuroscience, Carleton University, Ottawa, ON, Canada and Lara A. Pilutti, PhD, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

Trinh LT Huynh, MPH, Physical Therapy, University of Alabama at Birmingham, Birmingham, AL and Robert W Motl, PhD, Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL

Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil and Evanda S Oliveira, Reflexologist, Rehabilitation, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil

Clare T Hartigan, PT, MPT, Betty Mathew, SLP and Shannon Schneider, OTRL, Multiple Sclerosis Outpatient Rehabilitation, Shepherd Center, Atlanta, GA

Nicole Bou Rjeily, MD, Bardia Nourbakhsh, MD, MAS and Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Shlok Sarin, BS1, Alexander Wang, MD1,2, Mohamed Elkasaby, MD1,2 and Hesham Abboud, MD, PhD1,3, (1)Case Western Reserve School of Medicine – – Cleveland Heights, OH, Cleveland, OH, (2)University Hospitals Cleveland Medical Center, Cleveland, OH, (3)Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH

Shuvro Roy, MD, Paula Barreras, MD, Carlos Pardo, MD and Scott D. Newsome, DO, MSCS, FAAN, FANA, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Alexander Keenan, MA, MHP1, Kavita Gandhi, MS2, Hoa H. Le, PhD3, Ibrahim Turkoz, PhD4, Shien Guo, PhD5, Weiqin Liao, MPH, MS5 and Christopher Pelligra, MSc6, (1)Janssen Scientific Affairs, LLC, Titusville, NJ, (2)Janssen Global Market Access, LLC, Titusville, NJ, (3)Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, (4)Clinical Biostatistics, Janssen Research & Development, LLC, Titusville, NJ, (5)Evidera, Waltham, MA, (6)Evidera, Medellin, Colombia

David M. Kern, PhD, Janssen Research & Development, LLC, Titusville, NJ, Hoa H. Le, PhD, Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, Maria Ait-Tihyaty, PhD, Janssen Global Medical Affairs, LLC, Titusville, NJ and Alexander Keenan, MA, MHP, Janssen Scientific Affairs, LLC, Titusville, NJ

Allitia DiBernardo, MD1, Ibrahim Turkoz, PhD2, Michael Kutch, MS2 and Maria Ait-Tihyaty, PhD1, (1)Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, (2)Clinical Biostatistics, Janssen Research & Development, LLC, Titusville, NJ

Amber Salter, PhD1, Samantha Lancia, MS2, Ruth Ann Marrie, MD, PhD3, Gary R Cutter, PhD4, Robert J Fox, MD5, Sarah M England, PhD6, Shivani Kapadia, PharmD, RPh6, Sai L Shankar, PhD6 and James B Lewin, PharmD6, (1)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (2)Department of Biostatistics, UT Southwestern Medical Center, Dallas, TX, (3)Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, (4)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (5)Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (6)Biogen, Cambridge, MA

Amit Bar-Or, MD1, Kevin Winthrop, MD, MPH2, Heinz Wiendl, MD, MPH3, David Paling, MB ChB, MRCP, PhD4, Tobias Sejbaek, MD, PhD5,6, Carlo Pozzilli, MD, PhD7, Celine Louapre, MD, PhD8, Wendy Su, PhD9, Virginia DeLasHeras, MD10, Ronald Zielman, MD, PhD11, Roseanne Sullivan, PharmD9, Ayan Das Gupta, MSc12, Xixi Hu, PhD9 and Anne H. Cross, MD13, (1)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (3)University of Muenster, Muenster, Germany, (4)Department of Neurology, Royal Hallamshire Hospital, Sheffield, United Kingdom, (5)Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark, (6)Department of Regional Health Research, University of Southern Denmark, Odense, Denmark, (7)Department of Human Neuroscience, La Sapienza University, Rome, Italy, (8)Institut du cerveau, ICM, Sorbonne université, hôpital de la Pitié-Salpêtrière, INSERM UMR S 1127, CNRS UMR 7225, Paris, France, (9)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (10)Novartis Pharma AG, Basel, Switzerland, (11)Novartis Pharma B.V., Amsterdam, Netherlands, (12)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (13)Department of Neurology, Washington University in St. Louis, St. Louis, MO

Amit Bar-Or, MD1, Yang Mao-Draayer, MD, PhD2, Silvia R Delgado, MD3, Robert J Fox, MD4, Linda-Ali Cruz, MD5, Xiangyi Meng, PhD5, Gina Mavrikis Cox, PhD5 and Stanley L Cohan, MD, PhD6, (1)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Autoimmunity Center of Excellence, Multiple Sclerosis Center, University of Michigan, Ann Arbor, MI, (3)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (4)Cleveland Clinic, Cleveland, OH, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR

Deborah Chandler, ARNP DNP1, Amparo Gutierrez, MD FAAN1 and Orlando Health, (1)Neurology, Orlando Health, Orlando, FL

Bruce A.C. Cree, MD1, Krzysztof W. Selmaj, MD2, Lawrence Steinman, MD3, Giancarlo Comi, MD4, Amit Bar-Or, MD5, Douglas L. Arnold, MD6, Hans-Peter Hartung, MD7,8,9,10, Xavier Montalban, MD, PhD11, Eva K Havrdova, MD, PhD12, James K. Sheffield, MD, MBA, MS13, Neil Minton, MD FFPM13, Chun-Yen Cheng, PhD13, Diego Silva, MD13, Ludwig Kappos, MD14 and Jeffrey A Cohen, MD15, (1)Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Center for Neurology, ?ód?, Poland and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (3)Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (4)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (5)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada, (7)Heinrich-Heine University, Düsseldorf, Germany, (8)Brain and Mind Center, University of Sydney, Sydney, NSW, Australia, (9)Medical University of Vienna, Vienna, Austria, (10)Palacky University Olomouc, Olomouc, Czech Republic, (11)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, (12)Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, (13)Bristol Myers Squibb, Princeton, NJ, (14)Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (15)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

Chris M Kozma, PhD1, Emily Evans, MD, MBE2, Lori A Lebson, PhD3, Amy L Phillips, PharmD4 and Carroline Lobo, PhD4, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)Neurology and Immunology, EMD Serono, Rockland, MA, (3)EMD Serono, Rockland, MA, (4)North American Evidence and Value Development, EMD Serono, Rockland, MA

Daniel Sellers, MSCS, PA-C, Donald Negroski, MD, Amir Khiabani, DO and Devon Khiabani, DO, MS Center of Sarasota, Sarasota, FL

Douglas L Arnold, MD1, Colm Elliott, MD1, Xavier Montalban, MD PhD2, Emily C Martin, PhD3, Yann Hyvert, PhD4 and Davorka Tomic, PhD4, (1)NeuroRx Research, Montréal, QC, Canada, (2)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (3)EMD Serono, Billerica, MA, (4)The healthcare business of Merck KGaA, Darmstadt, Germany

Jens Kuhle, MD PhD1, Ludwig Kappos, MD2, Xavier Montalban, MD PhD3, Ying Li, MS4, Karthinathan Thangavelu, PhD4, Yann Hyvert, PhD5 and Davorka Tomic, PhD5, (1)Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, and University of Basel, Basel, Switzerland, (2)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, Basel, Switzerland, (3)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (4)EMD Serono, Billerica, MA, (5)The healthcare business of Merck KGaA, Darmstadt, Germany

Derrick Robertson, MD, University of South Florida, Tampa, FL, Lawrence Steinman, MD, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, Edward J Fox, MD, PhD, Central Texas Neurology Consultants, Round Rock, TX, Hans-Peter Hartung, MD, Heinrich Heine University, Dusseldorf, Germany; Department of Neurology, Medical University of Vienna, Vienna, Austria; Brain and Mind Centre, University of Sydney, Sydney, Australia; Department of Neurology, Palacky University, Olomouc, Czech Republic, Enrique Alvarez, MD, PhD, University of Colorado, Aurora, CO, Peiqing Qian, MD, Swedish Medical Center, Seattle, WA, Sibyl Wray, MD, Hope Neurology, Knoxville, TN, DeRen Huang, MD, PhD, Center for Multiple Sclerosis, Mount Carmel Health System, Westerville, OH, Krysztof Selmaj, MD, PhD, Center of Neurology, Lodz, Poland; Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Daniel Wynn, MD, Consultants in Neurology MS Center, Northbrook, IL, Koby Mok, PhD, TG Therapeutics, New York, NY, Christopher A Garner, PA-C, TG Therapeutics Inc, New York, NY and Bruce A Cree, MD, PhD, MAS, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

Derrick Robertson, MD, College of Medicine, Neurology, University of South Florida, Tampa, FL, Stephen L Hauser, PhD, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, Edward J Fox, MD, PhD, Central Texas Neurology Consultants, University of Texas Medical Branch, Round Rock, TX, Ludwig Kappos, MD, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Jeffrey A Cohen, MD, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, Angela Aungst, MPH, Multiple Sclerosis Division Department of Neurology University of South Florida, Florida, FL, Wendy Su, PhD, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Jing Xi, PhD, China Novartis Institutes For Biomedical Research Co., Ltd., Shanghai, China, Ayan Das Gupta, MSc, Novartis Healthcare Pvt. Ltd., Hyderabad, India and Dee Stoneman, MPharm, Novartis Pharma AG, Basel, Switzerland

Giordano Gentile, MSc1,2, Rozemarijn Mattiesing, MSc3, Iman Brouwer, MASc3, Dominic Jack, PhD4, Frederik Barkhof, MD, PhD3,5, Nicola De Stefano, MD, PhD1, Bernard MJ Uitdehaag, MD, PhD6, Hugo Vrenken, PhD3 and Marco Battaglini, PhD1,2, (1)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (2)SIENA imaging SRL, Siena, Italy, (3)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (4)Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom, (5)Institutes of Neurology and Healthcare Engineering, UCL London, London, United Kingdom, (6)Department of Neurology, MS Center Amsterdam, Amsterdam, Netherlands

Rozemarijn Mattiesing, MSc1, Giordano Gentile, MSc2,3, Iman Brouwer, MASc1, Dominic Jack, PhD4, Frederik Barkhof, MD, PhD1,5, Nicola De Stefano, MD, PhD2, Bernard MJ Uitdehaag, MD, PhD6, Jos WR Twisk, PhD7, Marco Battaglini, PhD2,3 and Hugo Vrenken, PhD1, (1)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (2)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (3)SIENA imaging SRL, Siena, Italy, (4)Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom, (5)Institutes of Neurology and Healthcare Engineering, UCL London, London, United Kingdom, (6)Department of Neurology, MS Center Amsterdam, Amsterdam, Netherlands, (7)Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands

Edward J Fox, MD, PhD, Central Texas Neurology Consultants, Round Rock, TX, Lawrence Steinman, MD, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, Hans-Peter Hartung, MD, Heinrich Heine University, Dusseldorf, Germany; Department of Neurology, Medical University of Vienna, Vienna, Austria; Department of Neurology, Palacky University, Olomouc, Czech Republic; Brain and Mind Centre, University of Sydney, Sydney, Australia, Enrique Alvarez, MD, PhD, University of Colorado, Aurora, CO, Peiqing Qian, MD, Swedish Medical Center, Seattle, WA, Sibyl Wray, MD, Hope Neurology, Knoxville, TN, Derrick Robertson, MD, University of South Florida, Tampa, FL, DeRen Huang, MD, PhD, Center for Multiple Sclerosis, Mount Carmel Health System, Westerville, OH, Krysztof Selmaj, MD, PhD, Center of Neurology, Lodz, Poland; Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Daniel Wynn, MD, Consultants in Neurology MS Center, Northbrook, IL, Koby Mok, PhD, TG Therapeutics, New York, NY, Denise Campagnolo, MD, TG Therapeutics Inc, New York, NY and Bruce A Cree, MD, PhD, MAS, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

Elizabeth A Douglas, MPH, Isabella O’Shea, B.S., Andrew J Bouley, M.D., Joshua D Katz, M.D. and Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

Elizabeth A Douglas, MPH, Isabella O’Shea, B.S., Andrew J Bouley, M.D., Joshua D Katz, M.D. and Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

Emma McFadden, PhD and Virginia R. Schobel, MSc, Neurology, Spherix Global Insights, Exton, PA

Abbi Blevins, PharmD, MBA, CSP1, Evan Turco, PharmD1, Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP2, Aimee Banks, PharmD, BCPS, MSCS2, Julie Wawrzyniak, PharmD, BCACP, MSCS3, Elizabeth Rightmier, PharmD, BCPS, MSCS3, Alicia Zagel, PhD, MPH4, Dana Simonson, PharmD, BCPS4, Josh DeClercq, MS5 and Leena Choi, PhD5, (1)Allied Health Solutions Specialty Pharmacy, WVUMedicine, Morgantown, WV, (2)Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, (3)University of Rochester Specialty Pharmacy, UR Medicine, Rochester, NY, (4)Fairview Specialty Pharmacy, Fairview Pharmacy Services, Minneapolis, MN, (5)Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN

Gina Mavrikis Cox, PhD1, Jeffrey A Cohen, MD2, Harald Kropshofer, PhD3, Xiangyi Meng, PhD1 and James Stankiewicz, MD1, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)Cleveland Clinic Mellen Center, Cleveland, OH, (3)Novartis Pharma AG, Basel, Switzerland

Gregory F Wu, MD, PhD1, Claudia Cantoni, PhD1, Amber Salter, PhD2, Kenneth Lee, BA1, Olaf Stuve, MD, PhD2, Amit Bar-Or, MD3, Gabriel Pardo, MD, FAAN4, Ursula Boschert, PhD5, Brooke Hayward, SM, MBA6, Julie Korich, PhD6, Lori A Lebson, PhD6 and Anne H. Cross, MD1, (1)Department of Neurology, Washington University in St. Louis, St. Louis, MO, (2)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (3)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Oklahoma Medical Research Foundation, Oklahoma City, OK, (5)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (6)EMD Serono, Rockland, MA

Hanke Zheng, PhD, Xiu Chen, PhD and Timothy Pham, MS, Bristol Myers Squibb, Princeton, NJ

Jeffrey Kaplan, MD1, Annette Okai, MD2, Peter Sguigna, MD3, Kyle Blackburn, MD3, Lauren Tardo, MD3, Brooke Hayward, SM, MBA4, Ursula Boschert, PhD5, Lori A Lebson, PhD4, Julie Korich, PhD4, Navid Manouchehri, MD3, Rehana Z Hussain, MSc3 and Olaf Stuve, MD, PhD6,7, (1)Kansas City Multiple Sclerosis and Headache Center, Overland Park, KS, (2)North Texas Institute of Neurology & Headache, Plano, TX, (3)University of Texas Southwestern Medical Center, Dallas, TX, (4)EMD Serono, Rockland, MA, (5)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (6)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (7)VA North Texas Health Care System, Dallas, TX

John DeLuca, PhD1,2, Jon V. Riolo, PhD3, Chun-Yen Cheng, PhD3, Robert T. Naismith, MD4, Sybil Wray, MD5, Ann Bass, MD6, Edward J Fox, MD, PhD7, Emily Riser, MD8, Diego Silva, MD3 and Robert Zivadinov, MD9, (1)Departments of Physical Medicine and Rehabilitation, and Neurology, Kessler Foundation, West Orange, NJ, (2)Rutgers – New Jersey Medical School, Newark, NJ, (3)Bristol Myers Squibb, Princeton, NJ, (4)Washington University School of Medicine, St Louis, MO, (5)Hope Neurology, Knoxville, TN, (6)Neurology Center of San Antonio, San Antonio, TX, (7)Central Texas Neurology Consultants, Round Rock, TX, (8)Alabama Neurology Associates, Birmingham, AL, (9)Neurology, Buffalo Neuroimaging Analysis Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY

John F Kramer, PA-C1, Patrick Vermersch, MD, PhD2, Roseanne Sullivan, PharmD3, Ronald Zielman, MD, PhD4, Xixi Hu, PhD3, Ayan Das Gupta, MSc5, Wendy Su, PhD3, Dee Stoneman, MPharm6, Elisabeth B Lucassen, MD3 and Olaf Hoffmann, PD Dr. med.7, (1)St Thomas Medical Partners, Nashville, TN, (2)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma B.V., Amsterdam, Netherlands, (5)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (6)Novartis Pharma AG, Basel, Switzerland, (7)Department of Neurology, Alexianer St. Josefs Hospital, Potsdam, Germany

Joseph R Berger, MD, FACP, FAAN, FANA1, Dina Jacobs, MD2, James Wilson, BA2, Emma Wilson, None2, Akash Virupakshaiah, MD2 and David Do, MD2, (1)Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Neurology, University of Pennsylvania, Philadelphia, PA

Kerstin Hellwig, MD, Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany, Bassem Yamout, MD, Harley Street Medical Center, Abu Dhabi, United Arab Emirates, Riley Bove, MD, University of California San Francisco, San Francisco, CA, Krishna Swetha Gummuluri, MBBS, Dip. Pharm. Med, Novartis Healthcare Pvt. Ltd., Hyderabad, India, Ulf Schulze Topphoff, PhD, Novartis Pharma GmbH, Nuremberg, Germany, Simone Fantaccini, MD, Novartis Pharma A.G., Basel, Switzerland, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Roseanne Sullivan, PharmD, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Maria Pia Amato, MD, Department NEUROFARBA, University of Florence, Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Ruth Dobson, PhD, FRCP, Department of Neurology, Royal London Hospital, BartsHealth NHS Trust, London, United Kingdom; Preventative Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom and Maria Houtchens, MD, Brigham Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA